NTRK gene amplification in patients with metastatic cancer
Su Jin Lee, Nayoung K. D. Kim, Se-Hoon Lee, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Woong Yang Park, Hee Jin Bang, Kyoung-Mee Kim, Keunchil Park, Jeeyun Lee
Precis Future Med. 2017;1(3):129-137.   Published online 2017 Sep 22     DOI: https://doi.org/10.23838/pfm.2017.00142
Citations to this article as recorded by Crossref logo
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma
Lucia Cappabianca, Veronica Zelli, Cristina Pellegrini, Michela Sebastiano, Rita Maccarone, Marco Clementi, Alessandro Chiominto, Pierdomenico Ruggeri, Ludovica Cardelli, Marianna Ruggieri, Maddalena Sbaffone, Maria-Concetta Fargnoli, Stefano Guadagni, An
Cells.2023; 12(2): 237.     CrossRef
Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas
Athina Stravodimou, Ioannis A Voutsadakis
World Journal of Clinical Oncology.2022; 13(2): 135.     CrossRef
Pan-TRK Immunohistochemistry and NTRK Gene Fusions in Primary Carcinomas of the Liver
Dongwei Zhang, Xiaoyan Liao
Applied Immunohistochemistry & Molecular Morphology.2022; 30(6): 435.     CrossRef
Tropomyosin receptor kinase protein expression in Thai cholangiocarcinoma: Clinicopathological correlation, expression pattern, and prognosis
Pimpika Leepisuth, Sasithorn Watcharadetwittaya, Prakasit Sa-ngiamwibool
Annals of Diagnostic Pathology.2022; 60: 151996.     CrossRef
Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data
Jihad Aljabban, Michael Rohr, Saad Syed, Eli Cohen, Naima Hashi, Sharjeel Syed, Kamal Khorfan, Hisham Aljabban, Vincent Borkowski, Michael Segal, Mohamed Mukhtar, Mohammed Mohammed, Emmanuel Boateng, Mary Nemer, Maryam Panahiazar, Dexter Hadley, Sajid Jal
World Journal of Gastrointestinal Oncology.2022; 14(9): 1856.     CrossRef
Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen
Albrecht Stenzinger, Cornelis M. van Tilburg, Ghazaleh Tabatabai, Florian Länger, Norbert Graf, Frank Griesinger, Lukas C. Heukamp, Michael Hummel, Thomas Klingebiel, Simone Hettmer, Christian Vokuhl, Sabine Merkelbach-Bruse, Friedrich Overkamp, Peter Rei
Der Pathologe.2021; 42(1): 103.     CrossRef
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
Hedvig Elfving, Erika Broström, Lotte N.J. Moens, Jonas Almlöf, Dijana Cerjan, Gilbert Lauter, Helena Nord, Johanna S.M. Mattsson, Gustav J. Ullenhag, Carina Strell, Max Backman, Linnéa La Fleur, Hans Brunnström, Johan Botling, Patrick Micke
Lung Cancer.2021; 151: 53.     CrossRef
Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer
Theodore W. Laetsch, David S. Hong
Clinical Cancer Research.2021; 27(18): 4974.     CrossRef
Entrectinib Induces Apoptosis and Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer with NTRK Overexpression
Sung-Hwa Sohn, Hee Jung Sul, Bum Jun Kim, Hyeong Su Kim, Dae Young Zang
International Journal of Molecular Sciences.2021; 23(1): 395.     CrossRef
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework
Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matt Stevenson, Stephen Palmer
Health Technology Assessment.2021; 25(76): 1.     CrossRef
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
James P. Solomon, Irina Linkov, Andrea Rosado, Kerry Mullaney, Ezra Y. Rosen, Denise Frosina, Achim A. Jungbluth, Ahmet Zehir, Ryma Benayed, Alexander Drilon, David M. Hyman, Marc Ladanyi, Anthony N. Sireci, Jaclyn F. Hechtman
Modern Pathology.2020; 33(1): 38.     CrossRef
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target
Alessandro Gambella, Rebecca Senetta, Giammarco Collemi, Stefano Gabriele Vallero, Matteo Monticelli, Fabio Cofano, Pietro Zeppa, Diego Garbossa, Alessia Pellerino, Roberta Rudà, Riccardo Soffietti, Franca Fagioli, Mauro Papotti, Paola Cassoni, Luca Berte
International Journal of Molecular Sciences.2020; 21(3): 753.     CrossRef
Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification
Dirk Hempel, Thomas Wieland, Beate Solfrank, Vera Grossmann, Johanna Steinhard, Andrea Frick, Louisa Hempel, Thomas Eberl, Andreas Gaumann
The Oncologist.2020; 25(6): e881.     CrossRef
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy
Susan J. Hsiao, Ahmet Zehir, Anthony N. Sireci, Dara L. Aisner
The Journal of Molecular Diagnostics.2019; 21(4): 553.     CrossRef
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
Antonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, Luciana Gneo, Cristina Pellegrini, Maria-Concetta Fargnoli, Andrew Reay Mackay
Journal of Experimental & Clinical Cancer Research.2018;[Epub]     CrossRef